Practice Management News

Healio spoke with Kaharu Sumino, MD, MPH, to discuss an American Thoracic Society International Conference presentation on asthma reliever options available internationally.

Less than 1 month since launch, Threads is the new darling of social media platforms. And, you may be unsure if you should be spending your valuable time on the platform to learn, educate or both.

Individuals with COVID-19 living in neighborhoods with high walkability and bikeability and less air pollution experienced fewer hospitalizations vs. areas with low mobility and more pollution, according to results published in PLoS ONE.

Treatment with neutralizing monoclonal antibodies in COVID-19 outpatients resulted in fewer hospital admissions and deaths vs. no antibody treatment, according to results published in CHEST.

With high expectations for independence in daily activities, 71% of survivors of acute respiratory failure achieved what they hoped for 6 months after discharge, according to results published in Annals of the American Thoracic Society.

Patients with COPD and cognitive impairment had heightened odds for inaccurate use of their inhaler 1 month after receiving training, according to study results published in BMC Pulmonary Medicine.

Compared with their peers, people with HIV experienced a smaller decline in mortality risk from COVID-19 during the omicron wave of the pandemic, researchers reported.

You’ve made the decision to sell your practice, got your house in order and hired advisers. Now you need to start making decisions regarding the terms of the sale.

Remote pulmonary rehabilitation during the COVID-19 pandemic demonstrated comparable outcomes to rehabilitation that took place in person prior to the pandemic, according to a research letter published in CHEST.

The FDA on Monday approved a monoclonal antibody for the prevention of respiratory syncytial virus lower respiratory tract disease in newborn and infants.